검색어 : 통합검색[Clark Tim]
총 1,115건 중 1,000건 출력
, 94/100 페이지
-
931
- Calmodulin Mutations Associated With Recurrent Cardiac Arrest in Infants
- Crotti, Lia; Johnson, Christopher N.; Graf, Elisabeth; De Ferrari, Gaetano M.; Cuneo, Bettina F.; Ovadia, Marc; Papagiannis, John; Feldkamp, Michael D.; Rathi, Subodh G.; Kunic, Jennifer D.; Pedrazzini, Matteo; Wieland, Thomas; Lichtner, Peter; Beckmann, Britt-Maria; Clark, Travis; Shaffer, Christian; Benson, D. Woodrow; Kä ä b, Stefan; Meitinger, Thomas; Strom, Tim M.; Chazin, Walter J.; Schwartz, Peter J.; George Jr, Alfred L.; From the Section of Cardiology, Department of Molecular Medicine, University of Pavia, Pavia, Italy (L.C., G.M.D.F., P.J.S.); Department of Cardiology, Fondazione IRCCS Policlinico S. Matteo, Pavia, Italy (L.C., G.M.D.F., M.P., P.J.S.); Institute of Human Genetics, Helmholtz Zentrum Mü nchen, Neuherberg, Germany (L.C., E.G., T.W., P.L., T.M., T.M.S.); Department of Biochemistry, Center for Structural Biology (C.N.J., M.D.F., S.G.R., W.J.C.), Division of Genetic Medicine, Department of Medicine (J.D.K...; From the Section of Cardiology, Department of Molecular Medicine, University of Pavia, Pavia, Italy (L.C., G.M.D.F., P.J.S.); Department of Cardiology, Fondazione IRCCS Policlinico S. Matteo, Pavia, Italy (L.C., G.M.D.F., M.P., P.J.S.); Institute of Human Genetics, Helmholtz Zentrum Mü nchen, Neuherberg, Germany (L.C., E.G., T.W., P.L., T.M., T.M.S.); Department of Biochemistry, Center for Structural Biology (C.N.J., M.D.F., S.G.R., W.J.C.), Division of Genetic Medicine, Depar; (Circulation, v.127, 2013, pp.1009-1017)
-
932
- Development of a highly sensitive liquid biopsy platform to detect clinically-relevant cancer mutations at low allele fractions in cell-free DNA
- Gale, Davina; Lawson, Andrew R. J.; Howarth, Karen; Madi, Mikidache; Durham, Bradley; Smalley, Sarah; Calaway, John; Blais, Shannon; Jones, Greg; Clark, James; Dimitrov, Peter; Pugh, Michelle; Woodhouse, Samuel; Epstein, Michael; Fernandez-Gonzalez, Ana; Whale, Alexandra S.; Huggett, Jim F.; Foy, Carole A.; Jones, Gerwyn M.; Raveh-Amit, Hadas; Schmitt, Karin; Devonshire, Alison; Green, Emma; Forshew, Tim; Plagnol, Vincent; Rosenfeld, Nitzan; Inivata Ltd, Granta Park, Cambridge, United Kingdom; Inivata Ltd, Granta Park, Cambridge, United Kingdom; Inivata Ltd, Granta Park, Cambridge, United Kingdom; Inivata Ltd, Granta Park, Cambridge, United Kingdom; Inivata Ltd, Granta Park, Cambridge, United Kingdom; Inivata Inc, Research Triangle Park, NC, United States of America; Inivata Inc, Research Triangle Park, NC, United States of America; Inivata Inc, Research Triangle Park, NC, United States of America; Inivata Inc, Research Triangle Park, NC, United States of America; Inivata Ltd, Granta Park, Cambridge, United Kingdom; Inivata Ltd, Granta Park, Cambridge, United Kingdom; Inivata Ltd, Granta Park, Cambridge, United Kingdom; Inivata Ltd, Granta Park, Cambridge, United Kingdom; Inivata Ltd, Granta Park, Cambridge, United Kingdom; LGC, Teddington, Middlesex, United Kingdom; LGC, Teddington, Middlesex, United Kingdom; LGC, Teddington, Middlesex, United Kingdom; LGC, Teddington, Middlesex, United Kingdom; LGC, Ted; (PloS one, v.13, 2018, pp.e0194630)
-
933
- Epic: A Phase 3 Trial of Ponatinib Compared with Imatinib in Patients with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CP-CML)
- Lipton, Jeffrey H.; Chuah, Charles; Guerci-Bresler, Agnes; Rosti, Gianantonio; Simpson, David; Assouline, Sarit; Etienne, Gabriel; Nicolini, Franck E.; Le Coutre, Philipp; Clark, Richard; Stenke, Leif; Andorsky, David; Oehler, Vivian; Lustgarten, Stephanie; Rivera, Victor M.; Clackson, Tim; Haluska, Frank G; Baccarani, Michele; Cortes, Jorge E.; Guilhot, Francois; Hochhaus, Andreas; Hughes, Timothy P.; Kantarjian, Hagop M.; Shah, Neil P.; Talpaz, Moshe; Deininger, Michael W.; Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada; Singapore General Hospital, Duke-NUS Graduate Medical School, Singapore, Singapore; Service d'Hé matologie CHU Hopitaux de Brabois, Vandoeuvre Cedex, France; S Orsola-Malpighi University Hospital, Bologna, Italy; North Shore Hospital, Auckland, New Zealand; McGill University, Montreal, Canada; Institut Bergonié , Bordeaux, France; Centre Hospitalier Lyon Sud, Pierre-Bé nite, Pierre Bé nite, France; Charité -Universitä tsmedizin Berlin, Berlin, Germany; Royal Liverpool University Hospital, Merseyside, United Kingdom; Karolinska University Hospital, Solna, Sweden; Rocky Mountain Cancer Centers, Boulder, CO; Fred Hutchinson Cancer Research Center, Seattle, WA; ARIAD Pharmaceuticals, Inc., Cambridge, MA; ARIAD Pharmaceuticals, Inc., Cambridge, MA; ARIAD Pharmaceuticals, Inc., Cambridge, MA; ARIAD Pharmaceuticals, Inc., Cambridge, MA; S Orsola-Malpighi University Hospi; (Blood, v.124, 2014, pp.519-519)
-
934
- An overview of the NEMO modelling for the BaySys project
- Myers, Paul G.; Barber, David; Braun, Marco; Buchart, Liam; de la Guardia, Laura Castro; Deschepper, Inge; Dupont, Frederic; Ehn, Jens; Garcia-Quintana, Yarisbel; Gillard, Laura C.; Grivault, Nathan; Hu, Xianmin; Kirillov, Sergei A.; Jafarikhasragh, Shabnam; Lukovich, Jennifer; Maps, Frederic; Marson, Juliana M.; Papakyriakou, Tim; Pennelly, Clark; Ridenour, Natasha; Stadnyk, Tricia A.; Sydor, Kevin; Tao, Ran; Tefs, Andrew; Tremblay, Jean-É ric; Xu, Yiran; 1Department of Earth and Atmospheric Sciences, University of Alberta, Edmonton, AB, Canada; 2Centre for Earth Observation Science, University of Manitoba, Winnipeg, MB, Canada; 3Ouranos Consortium, Montreal, QC, Canada; 1Department of Earth and Atmospheric Sciences, University of Alberta, Edmonton, AB, Canada; 1Department of Earth and Atmospheric Sciences, University of Alberta, Edmonton, AB, Canada; 1Department of Earth and Atmospheric Sciences, University of Alberta, Edmonton, AB, Canada; 5Meteorologique du Canada, Environnement et Changement Climatique Canada, Dorval, QC, Canada; 2Centre for Earth Observation Science, University of Manitoba, Winnipeg, MB, Canada; 1Department of Earth and Atmospheric Sciences, University of Alberta, Edmonton, AB, Canada; 1Department of Earth and Atmospheric Sciences, University of Alberta, Edmonton, AB, Canada; 1Department of Earth and Atmospheric Sciences, University of Alberta, Edmonton, AB, Canada; 1Department of Earth and Atmospheric S; (Elementa : science of the anthropocene, v.12, 2024, pp.00111)
-
935
- Inhibition of Nuclear PTEN Tyrosine Phosphorylation Enhances Glioma Radiation Sensitivity through Attenuated DNA Repair
-
Ma, Jianhui;
Benitez, Jorge A.;
Li, Jie;
Miki, Shunichiro;
Ponte de Albuquerque, Claudio;
Galatro, Thais;
Orellana, Laura;
Zanca, Ciro;
Reed, Rachel;
Boyer, Antonia;
Koga, Tomoyuki;
Varki, Nissi M.;
Fenton, Tim R.;
Nagahashi Marie, Suely Kazue;
Lindahl, Erik;
Gahman, Timothy C.;
Shiau, Andrew K.;
Zhou, Huilin;
DeGroot, John;
Sulman, Erik P.;
Cavenee, Webster K.;
Kolodner, Richard D.;
Chen, Clark C.;
Furnari, Frank B.;
Ludwig Institute for Cancer Research, San Diego Branch, University of California at San Diego;
Ludwig Institute for Cancer Research, San Diego Branch, University of California at San Diego;
Department of Neurosurgery, University of Minnesota;
Ludwig Institute for Cancer Research, San Diego Branch, University of California at San Diego;
Ludwig Institute for Cancer Research, San Diego Branch, University of California at San Diego;
Department of Neurology, Laboratory of Molecular and Cellular Biology, LIM15, School of Medicine, University of Sã
o Paulo;
Science for Life Laboratory;
Ludwig Institute for Cancer Research, San Diego Branch, University of California at San Diego;
Ludwig Institute for Cancer Research, San Diego Branch, University of California at San Diego
USA
-
936
- Abstract GS3-10: Partitioning of cancer therapeutics in nuclear condensates
- Klein, Isaac; Boija, Ann; Afeyan, Lena; Hawken, Susana Wilson; Fan, Mengyang; Dall'Agnese, Alessandra; Oksuz, Ozgur; Henninger, Jonathan; Shrinivas, Krishna; Sabari, Benjamin; Sagi, Ido; Clark, Victoria; Platt, Jesse; Kar, Mrityunjoy; McCall, Patrick; Zamudio, Alicia; Mantiega, John; Coffey, Eliot; Li, Charles; Hannett, Nancy; Guo, Yang; Decker, Tim-Michael; Lee, Tong; Zhang, Tinghu; Weng, Jing-Ke; Taatjes, Dylan; Chakraborty, Arup; Sharp, Phillip; Chang, Young Tae; Hyman, Anthony; Gray, Nathanael; Young, Richard; ; (Cancer research : the official organ of the American Association for Cancer Research, Inc, v.81, 2021, pp.GS3-10-GS3-10)
-
937
- Rethinking clinical placements: A response to changing healthcare demands
- Rudland, Joy; Ash, Julie; Barclay, Luke; Bloomfield, Jacqueline; Bogossian, Fiona; Byrne, Kaylenne; Butler, Mary; Chur-Hansen, Anna; Clark, Scott; Edgar, Amanda; Fotheringham, Penelope; Forbes, Roma; Green, Elyce; Haworth, Navine; Hays, Richard; Judd, Belinda; Martin, Priya; Macdiarmid, Rachel; McNally, Clare; McNeill, Liz; McGee, Richard; Needham, Judith; Poole, Phillippa; Raymond, Jacqueline; Ridd, Melissa; Schoo, Adrian; Tran, Michael; Virtue, Debra; Wilkinson, Tim; Wright, John; Ní Chró iní n, Danielle; ; (Focus on health professional education, v.26, 2025, pp.60-77)
-
938
- A Systematically Improved High Quality Genome and Transcriptome of the Human Blood Fluke <i>Schistosoma mansoni</i>
- Protasio, Anna V.; Tsai, Isheng J.; Babbage, Anne; Nichol, Sarah; Hunt, Martin; Aslett, Martin A.; De Silva, Nishadi; Velarde, Giles S.; Anderson, Tim J. C.; Clark, Richard C.; Davidson, Claire; Dillon, Gary P.; Holroyd, Nancy E.; LoVerde, Philip T.; Lloyd, Christine; McQuillan, Jacquelline; Oliveira, Guilherme; Otto, Thomas D.; Parker-Manuel, Sophia J.; Quail, Michael A.; Wilson, R. Alan; Zerlotini, Adhemar; Dunne, David W.; Berriman, Matthew; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, United Kingdom; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, United Kingdom; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, United Kingdom; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, United Kingdom; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, United Kingdom; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, United Kingdom; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, United Kingdom; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, United Kingdom; Texas Biomedical Research Institute, San Antonio, Texas, United States of America; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, United Kingdom; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, United Kingdom; Wellcome Trust Sanger Inst; (PLoS neglected tropical diseases, v.6, 2012, pp.e1455)
-
939
- Urinary proteomic signature of mineralocorticoid receptor antagonism by spironolactone: evidence from the HOMAGE trial
- Yu, Yu-Ling; Siwy, Justyna; An, De-Wei; Gonzá lez, Arantxa; Hansen, Tine; Latosinska, Agnieszka; Pellicori, Pierpaolo; Ravassa, Susana; Mariottoni, Beatrice; Verdonschot, Job AJ; Ahmed, Fozia; Petutschnigg, Johannes; Rossignol, Patrick; Heymans, Stephane; Cuthbert, Joe J; Girerd, Nicolas; Clark, Andrew L; Verhamme, Peter; Nawrot, Tim S; Janssens, Stefan; Cleland, John G; Zannad, Faiez; Diez, Javier; Mischak, Harald; Ferreira, Joã o Pedro; Staessen, Jan A; Research Unit Environment and Health, KU Leuven Department of Public Health and Primary Care, University of Leuven, , Leuven, Belgium; Mosaiques-Diagnostics GmbH, , Hannover, Germany; Research Unit Environment and Health, KU Leuven Department of Public Health and Primary Care, University of Leuven, , Leuven, Belgium; Program of Cardiovascular Diseases, CIMA, Universidad de Navarra and IdiSNA, Pamplona, Spain CIBERCV, Carlos III Institute of Health, , Madrid, Spain; Non-Profit Research Association Alliance for the Promotion of Preventive Medicine (APPREMED), , Mechelen, Belgium; Mosaiques-Diagnostics GmbH, , Hannover, Germany; Université de Lorraine, Inserm, , Centre d’Investigation Clinique Plurithé matique 1433, U1116, CHRU de Nancy, F-CRIN INI-CRCT, Nancy, France; Program of Cardiovascular Diseases, CIMA, Universidad de Navarra and IdiSNA, Pamplona, Spain CIBERCV, Carlos III Institute of Health, , Madrid, Spain; Department of Cardiology, Cortona Hospital, , Are; (Heart : official journal of the British Cardiac Society, v.110, 2024, pp.1180-1187)
-
940
- 3102 – A SYNTHETIC LETHALITY APPROACH TO ERADICATE AML VIA SYNERGISTIC ACTIVATION OF PRO-APOPTOTIC P53 BY MDM2 AND BET INHIBITORS
-
Li, Sha;
Latif, Anne-Louise;
Newcombe, Ashley;
Gilrory, Kathryn;
Robertson, Neil;
Finlay, Darren;
Lei, Xue;
Stewart, Helen;
Barbosa, Karina;
Cole, John;
Terradas, Maria Terradas;
Rishi, Loveena;
McGarry, Lynn;
McKeeve, Claire;
Reid, Claire;
Clark, William;
Campos, Joana;
Kirschner, Kristina;
Lopez, Jonathan;
Sakamaki, Jun-Ichi;
Morton, Jennifer;
Ryan, Kevin;
Tait, Stephen;
Abraham, Sheela;
Holyoake, Tessa;
Higgins, Brian;
Huang, Xu;
Copland, Mhairi;
Chevassut, Tim;
Deshpande, Ani;
Keeshan, Karen;
Adams, Peter;
Sanford Burnham Prebys Medical Discovery Institute;
University of Glasgow;
University of Glasgow;
University of Glasgow;
University of Glasgow;
Sanford Burnham Prebys Medical Discovery Institute;
Sanford Burnham Prebys Medical Discovery Institute;
University of Sussex;
Sanford Burnham Prebys Medical Discovery Institute;
University of Glasgow;
University of Glasgow;
University of Glasgow;
Cancer Research UK Beatson Institute;
Queen Elizabeth Univeristy Hospital;
University of Glasgow
United Kingdom
QUICK MENU
